| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,390 |
12,911 |
$998K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
6,444 |
6,242 |
$592K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,788 |
5,646 |
$258K |
| 87631 |
|
1,333 |
1,315 |
$200K |
| T1015 |
Clinic visit/encounter, all-inclusive |
5,499 |
1,854 |
$169K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
927 |
909 |
$161K |
| G0378 |
Hospital observation service, per hour |
177 |
173 |
$153K |
| 80053 |
Comprehensive metabolic panel |
12,657 |
11,768 |
$136K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
636 |
613 |
$119K |
| X0621 |
|
372 |
233 |
$87K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,753 |
13,328 |
$80K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,550 |
2,457 |
$76K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,566 |
1,510 |
$70K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,523 |
1,490 |
$64K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
306 |
300 |
$62K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,764 |
1,603 |
$55K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,017 |
3,870 |
$50K |
| 450 |
Pov group 1 hd 301-450 lbs |
65 |
49 |
$48K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,000 |
4,654 |
$46K |
| 70450 |
Computed tomography, head or brain; without contrast material |
855 |
821 |
$44K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
502 |
499 |
$44K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,311 |
2,152 |
$41K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,734 |
1,687 |
$38K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
545 |
518 |
$33K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
398 |
375 |
$31K |
| 93976 |
|
307 |
298 |
$27K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
775 |
727 |
$26K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
278 |
271 |
$23K |
| 81001 |
|
6,938 |
6,616 |
$21K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
123 |
123 |
$20K |
| 93971 |
|
317 |
307 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
1,571 |
1,522 |
$19K |
| 84484 |
|
2,192 |
1,686 |
$19K |
| 87150 |
|
276 |
266 |
$19K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,347 |
2,204 |
$18K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
446 |
437 |
$17K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
257 |
255 |
$17K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
645 |
636 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
645 |
636 |
$17K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,279 |
1,206 |
$17K |
| 80061 |
Lipid panel |
1,271 |
1,253 |
$16K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
454 |
452 |
$16K |
| 84703 |
|
1,360 |
1,314 |
$15K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
394 |
387 |
$14K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
402 |
393 |
$13K |
| 97162 |
|
321 |
309 |
$13K |
| 76830 |
Ultrasound, transvaginal |
252 |
244 |
$12K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
200 |
199 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,704 |
1,418 |
$12K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
499 |
496 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
45 |
44 |
$11K |
| 76536 |
|
241 |
240 |
$11K |
| 97161 |
|
270 |
258 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
695 |
672 |
$9K |
| 84702 |
|
510 |
435 |
$9K |
| 76642 |
|
235 |
229 |
$9K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
256 |
250 |
$9K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
191 |
190 |
$9K |
| 76770 |
|
190 |
187 |
$8K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
150 |
150 |
$8K |
| 87040 |
|
612 |
371 |
$7K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
161 |
152 |
$7K |
| 80050 |
General health panel |
146 |
143 |
$6K |
| 86803 |
|
291 |
289 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
878 |
850 |
$6K |
| 85379 |
|
584 |
569 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
967 |
951 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
609 |
503 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,097 |
2,898 |
$6K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
12 |
12 |
$6K |
| 83690 |
|
1,149 |
1,080 |
$5K |
| 83605 |
|
807 |
727 |
$5K |
| 87088 |
|
635 |
613 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
193 |
190 |
$5K |
| 73610 |
|
268 |
263 |
$5K |
| 86787 |
|
237 |
236 |
$5K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
77 |
71 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
3,733 |
3,199 |
$4K |
| 78227 |
|
14 |
14 |
$4K |
| 86850 |
|
538 |
526 |
$4K |
| 87186 |
|
555 |
539 |
$4K |
| 76801 |
|
91 |
88 |
$4K |
| 73564 |
|
190 |
189 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
198 |
197 |
$4K |
| 86762 |
|
153 |
152 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
68 |
60 |
$3K |
| 72141 |
|
13 |
13 |
$3K |
| 83735 |
|
559 |
483 |
$3K |
| 73221 |
|
14 |
14 |
$3K |
| 82728 |
|
277 |
269 |
$3K |
| 83880 |
|
172 |
154 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
196 |
138 |
$3K |
| 320 |
|
18 |
15 |
$3K |
| 84439 |
|
346 |
338 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
303 |
237 |
$3K |
| 70486 |
|
40 |
40 |
$2K |
| 73030 |
|
196 |
189 |
$2K |
| 87071 |
|
417 |
412 |
$2K |
| 70496 |
|
12 |
12 |
$2K |
| 73630 |
|
211 |
208 |
$2K |
| 82607 |
|
219 |
219 |
$2K |
| 74018 |
|
191 |
189 |
$2K |
| 96367 |
|
120 |
113 |
$2K |
| 86900 |
|
575 |
561 |
$2K |
| 86901 |
|
570 |
556 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
335 |
95 |
$2K |
| 97597 |
|
145 |
93 |
$2K |
| 82950 |
|
269 |
269 |
$2K |
| 85610 |
|
794 |
632 |
$2K |
| A9270 |
Non-covered item or service |
195 |
188 |
$2K |
| 80076 |
|
191 |
185 |
$2K |
| 82570 |
|
254 |
241 |
$2K |
| 86038 |
|
109 |
109 |
$2K |
| 73130 |
|
158 |
153 |
$2K |
| 87340 |
|
120 |
119 |
$2K |
| 72100 |
|
89 |
87 |
$2K |
| 85730 |
|
311 |
300 |
$2K |
| 93017 |
|
67 |
66 |
$2K |
| 83540 |
|
191 |
189 |
$2K |
| 96376 |
|
55 |
47 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27 |
24 |
$2K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
90 |
89 |
$2K |
| 81025 |
|
227 |
219 |
$1K |
| 87077 |
|
142 |
141 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
25 |
25 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
43 |
43 |
$1K |
| 85652 |
|
409 |
396 |
$1K |
| 86140 |
|
429 |
398 |
$1K |
| 99215 |
Prolong outpt/office vis |
16 |
14 |
$998.62 |
| 81003 |
|
334 |
329 |
$988.47 |
| 86592 |
|
225 |
222 |
$978.23 |
| 12001 |
|
14 |
14 |
$890.64 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,789 |
3,419 |
$801.59 |
| 300 |
Patient transfer system <300 |
101 |
27 |
$800.61 |
| 82948 |
|
309 |
253 |
$779.10 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
106 |
106 |
$767.21 |
| 77065 |
Tomosynthesis, mammo |
12 |
12 |
$758.21 |
| 73110 |
|
64 |
63 |
$746.71 |
| 86318 |
|
32 |
32 |
$718.55 |
| 93970 |
|
13 |
12 |
$701.01 |
| 82010 |
|
173 |
155 |
$697.42 |
| 84145 |
|
64 |
52 |
$632.67 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$614.95 |
| 93925 |
|
14 |
14 |
$597.88 |
| 90715 |
|
50 |
50 |
$577.53 |
| 82043 |
|
73 |
72 |
$570.43 |
| 87081 |
|
94 |
93 |
$557.88 |
| 84100 |
|
130 |
101 |
$542.27 |
| 87641 |
|
15 |
15 |
$524.64 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
378 |
312 |
$513.74 |
| 73502 |
|
28 |
28 |
$476.61 |
| 82550 |
|
73 |
67 |
$458.93 |
| 73562 |
|
30 |
27 |
$448.62 |
| 84466 |
|
25 |
25 |
$415.81 |
| 82803 |
|
17 |
15 |
$382.40 |
| 86618 |
|
13 |
13 |
$369.62 |
| 86431 |
|
42 |
42 |
$364.60 |
| 82947 |
|
78 |
77 |
$354.15 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
12 |
$333.08 |
| 86922 |
|
12 |
12 |
$330.40 |
| 85018 |
|
121 |
108 |
$295.67 |
| 84146 |
|
12 |
12 |
$273.63 |
| 71250 |
|
12 |
12 |
$264.95 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,657 |
2,410 |
$236.67 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
23 |
14 |
$236.54 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
746 |
717 |
$225.93 |
| 87808 |
|
12 |
12 |
$169.91 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
259 |
241 |
$164.53 |
| 73080 |
|
13 |
13 |
$154.96 |
| 83655 |
|
12 |
12 |
$146.00 |
| 84550 |
|
29 |
25 |
$144.85 |
| 83615 |
|
31 |
24 |
$126.35 |
| 84156 |
|
25 |
24 |
$117.97 |
| 85027 |
|
15 |
14 |
$113.56 |
| 87070 |
|
12 |
12 |
$104.16 |
| 82375 |
|
18 |
16 |
$80.11 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
457 |
281 |
$63.59 |
| 83050 |
|
17 |
15 |
$42.89 |
| 86905 |
|
13 |
13 |
$36.26 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
213 |
193 |
$30.30 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
121 |
110 |
$25.52 |
| J2704 |
Injection, propofol, 10 mg |
40 |
38 |
$20.80 |
| J7050 |
Infusion, normal saline solution, 250 cc |
56 |
39 |
$11.86 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
20 |
12 |
$11.28 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
125 |
56 |
$11.04 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
196 |
182 |
$10.04 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
25 |
25 |
$9.81 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
53 |
51 |
$4.45 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
203 |
195 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
102 |
101 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
457 |
441 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
148 |
141 |
$0.00 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
17 |
17 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
17 |
15 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
203 |
158 |
$0.00 |